Mirexus Biotechnologies Inc.
$200,000.00 CAD
≈ 3 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- April 1, 2018 – February 28, 2019
- Reference
- nrc-cnrc:172-2018-2019-Q1-907205
Published purpose
Mirexus’ proprietary material - trademarked NanoDendrix™ (NaD) is a platform for the development of multiple pharmaceutical applications of safe and natural nanotechnology. Early discovery research has shown selected derivatives can be modified to regulate (either enhance or inhibit) the interferon mediated innate immune response. This further can be used to enable the enhanced production of viruses grown in cell cultures…a potentially disruptive advance in the virus production industry.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions